
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
TLR4 CRISPR/Cas9 KO Plasmid (m) | sc-423419 | 20 µg | $397.00 | |||
TLR4 HDR Plasmid (m) | sc-423419-HDR | 20 µg | $445.00 |
Tlr4 encodes toll-like receptor 4 (TLR4), a pattern-recognition receptor that detects bacterial lipopolysaccharide and select endogenous danger-associated ligands to initiate innate immune signaling. Upon activation, TLR4 engages both MyD88- and TRIF-dependent pathways, driving NF-κB and IRF3 transcriptional programs that regulate pro-inflammatory cytokines, type I interferon responses, and costimulatory molecule expression. In mouse macrophages, dendritic cells, and barrier tissues, TLR4 signaling shapes leukocyte recruitment, antigen presentation, and tissue remodeling. Dysregulated TLR4 activity has been implicated in models of sepsis-like inflammation, metabolic inflammation, neuroinflammation, and autoimmune phenotypes, making it a common target for mechanistic studies of host defense and sterile inflammatory processes.
TLR4 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Tlr4 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Tlr4 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, TLR4 HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Tlr4 target site.
When co-transfected with TLR4 CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Tlr4 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.